Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Phase 1/1B trial of the heat shock protein 90 inhibitor NVP-AUY922 as monotherapy or in combination with bortezomib in patients with relapsed or refractory multiple myeloma

Seggewiss-Bernhardt, Ruth, Bargou, Ralf C., Goh, Yeow Tee, Stewart, A. Keith, Spencer, Andrew, Alegre, Adrian, Blade, Joan, Ottmann, Oliver, Fernandez-Ibarra, Cristina, Lu, Hong, Pain, Scott, Akimov, Mikhail and Iyer, Swaminathan Padmanabhan 2015. Phase 1/1B trial of the heat shock protein 90 inhibitor NVP-AUY922 as monotherapy or in combination with bortezomib in patients with relapsed or refractory multiple myeloma. Cancer 121 (13) , pp. 2185-2192.

Full text not available from this repository.
Item Type: Article
Status: Published
Schools: Medicine
Subjects: R Medicine > R Medicine (General)
Publisher: Elsevier
ISSN: 0008-543X
Last Modified: 04 Jun 2017 09:33
URI: http://orca.cf.ac.uk/id/eprint/96768

Citation Data

Cited 13 times in Google Scholar. View in Google Scholar

Cited 16 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item